DN
Therapeutic Areas
Juniper Biomedical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Precision Neuromodulation Platform | Pelvic Health Disorders (e.g., Urinary Incontinence, Bowel Incontinence, Pelvic Pain) | Pre-clinical |
Leadership Team at Juniper Biomedical
MR
Mario Romero-Ortega, PhD
Co-Founder & Chief Science Officer
GM
Gregory Martin, PhD
Chief Technology Officer
JC
Jayme Coates, MS, MBA
Chief Operating Officer
JD
Jessica DeLong, MD, FACS
Chief Medical Officer
RS
Robert Swain, PhD
Clinical & Regulatory Affairs